Article
Efficacy and Safety of palbociclib (PAL) in Patients (pts) with Estrogen Receptor-positive (ER+)/human Epidermal Growth Factor Receptor 2-negative (HER2-) Advanced Breast Cancer (ABC) with Preexisting Conditions: A Post Hoc Analysis of PALOMA-2
Cancer Research / San Antonio Breast Cancer Symposium
(2021)
Abstract
K. Gelmon; J. Walshe; A. Joy; M. Karturi; P. Neven; D. Lu; S. Kim; P. Schnell
Disciplines
Publication Date
February 15, 2021
Citation Information
Reshma Mahtani. "Efficacy and Safety of palbociclib (PAL) in Patients (pts) with Estrogen Receptor-positive (ER+)/human Epidermal Growth Factor Receptor 2-negative (HER2-) Advanced Breast Cancer (ABC) with Preexisting Conditions: A Post Hoc Analysis of PALOMA-2" Cancer Research / San Antonio Breast Cancer Symposium Vol. 81 Iss. 4 Supplement (2021) Available at: http://works.bepress.com/reshma-mahtani/46/